Anticancer therapy with novel tubulin-interacting drugs

This publication has 77 references indexed in Scilit:

• Factors determining cellular mechanisms of resistance to antimitotic drugs
  Drug Resistance Updates, 2001
• A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins
  JNCI Journal of the National Cancer Institute, 2000
• A β-Tubulin Leucine Cluster Involved in Microtubule Assembly and Paclitaxel Resistance
  Journal of Biological Chemistry, 1999
• Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell Lines
  JNCI Journal of the National Cancer Institute, 1999
• Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
  Journal of Clinical Investigation, 1997
• Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization
  Journal of Biological Chemistry, 1997
• The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance
  Anti-Cancer Drugs, 1997
• Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
  Proceedings of the National Academy of Sciences, 1993
• BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
  Annual Review of Biochemistry, 1993
• Taxol stabilizes microtubules in mouse fibroblast cells.
  Proceedings of the National Academy of Sciences, 1980